GEND Genter Capital Dividend Income ETF
ETF on NYSE (US) · Actively managed · Listing
Most notable sale · Coterra Energy Inc
Coterra Energy Inc sold out
Units went from 5,553 to 0 ($199K → $0). Was 4.5% of the Apr 30, 2026 portfolio.
Most notable buy · Devon Energy Corporation
New position in Devon Energy Corporation
4,109 shares worth $185K. Now 3.8% of the portfolio.
Largest holding: Northern Trust Corporation, raised 6%, 1,245 shares ($227K).
| Current positions Top 10 | % of book |
|---|---|
| Northern Trust Corporation NTRS $227K · +6% sh | 4.7% |
| CVS Health Corporation CVS $217K · +6% sh | 4.5% |
| Enbridge Inc ENB $200K · +6% sh | 4.1% |
| JP Morgan Chase & Co. JPM $196K · +6% sh | 4.0% |
| M&T Bank Corporation MTB $190K · −7% sh | 3.9% |
| Altria Group, Inc. MO $188K · +6% sh | 3.9% |
| Devon Energy Corporation DVN $185K · NEW | 3.8% |
| Accenture plc ACN $185K · 2.5x sh | 3.8% |
| Chevron Corporation CVX $184K · +6% sh | 3.8% |
| Goldman Sachs Financ FGTXX $183K · 5.7x units | 3.8% |
Slices are % of holdings value. Changes ("sh" shares, "units" other holdings) are in the quantity held against Apr 30, 2026.
| Sectors | % of holdings value |
|---|---|
| Healthcare | 20.9% |
| Financial Services | 18.1% |
| Energy | 15.2% |
| Industrials | 8.6% |
| Technology | 8.4% |
| Consumer Defensive | 6.9% |
| Communication Services | 5.9% |
| Utilities | 5.5% |
| Other (2) | 6.8% |
| Unclassified | 3.8% |
| Industries | % of holdings value |
|---|---|
| Banks - Diversified | 15.4% |
| Drug Manufacturers - General | 11.2% |
| Telecom Services | 5.9% |
| Utilities - Regulated Electric | 5.5% |
| Healthcare Plans | 4.5% |
| Oil & Gas Midstream | 4.1% |
| Tobacco | 3.9% |
| Other (17) | 45.8% |
| Unclassified | 3.8% |
| Initiations 1 | Value |
|---|---|
| Devon Energy Corporation DVN 3.8% of portfolio | $185K |
| Increases 27 | Change |
|---|---|
| Accenture plc ACN $79.7K → $185K | 2.5x |
| Medtronic plc. MDT $71.5K → $135K | +80% |
| Comcast Corporation CMCSA $113K → $155K | +55% |
| AT&T Inc. T $134K → $133K | +12% |
| Northern Trust Corporation NTRS $196K → $227K | +6% |
| CVS Health Corporation CVS $164K → $217K | +6% |
| Enbridge Inc ENB $192K → $200K | +6% |
| JP Morgan Chase & Co. JPM $165K → $196K | +6% |
| Altria Group, Inc. MO $189K → $188K | +6% |
| Chevron Corporation CVX $171K → $184K | +6% |
| Merck & Company, Inc. MRK $139K → $175K | +6% |
| Phillips 66 PSX $133K → $166K | +6% |
| Reductions 4 | Change |
|---|---|
| Cisco Systems, Inc. CSCO $215K → $96.7K | −65% |
| Johnson & Johnson JNJ $139K → $125K | −19% |
| Gilead Sciences, Inc. GILD $134K → $116K | −13% |
| M&T Bank Corporation MTB $182K → $190K | −7% |
| Terminations 5 | Change |
|---|---|
| Coterra Energy Inc CTRA was $199K | −100% |
| Corning Incorporated GLW was $72.1K | −100% |
| Chevron Corp OPTION (short) was −$1.10K | −100% |
| Gilead Sciences Inc OPTION (short) was −$235 | −100% |
| Johnson & Johnson OPTION (short) was −$66 | −100% |
The other 15 increases
Emerson Electric Company (+6%), United Parcel Service, Inc. (+6%), PepsiCo, Inc. (+6%), Evergy, Inc. (+6%), Capital One Financial Corporation (+6%), AbbVie Inc. (+6%), Microchip Technology Incorporated (+6%), DBA Sempra (+6%), BlackRock, Inc. (+5%), Air Products and Chemicals, Inc. (+6%), Bristol-Myers Squibb Company (+6%), Lockheed Martin Corporation (+5%), CRH PLC (+6%), Home Depot, Inc. (The) (+6%), LKQ Corporation (+6%)
Source: the fund's quarterly portfolio reports to the SEC, the portfolio of Jul 31, 2026 (Form N-PORT) vs the portfolio of Apr 30, 2026 (Form N-PORT). Percent changes are changes in the quantity held (shares, or units for holdings that are not a listed equity); dollar values are as reported at each period end. Each column is ranked by the estimated dollar size of the trade: a new or closed position at its value, otherwise the change in shares at the position's own period-end price. Where shares and price per share moved by inverse whole multiples (a split), the earlier share count is restated. Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.
Objective
From the summary prospectus filed Sep 11, 2026.
Genter Capital Dividend Income ETF (the "Fund") seeks current income and long-term capital appreciation.
Principal investment strategies
Under normal market conditions, the Fund will invest at least 80% of its assets plus borrowings for investment purposes in domestic equity securities that have records of paying dividends. The Fund will invest primarily in companies with market capitalizations of $2 billion or higher at the time of initial purchase. In addition, the Fund will invest in a diversified portfolio of 25 to 50 securities typically spread across many economic sectors. Investments in and weightings of individual sectors will vary based on the Fund's investment sub-advisor's, RNC Capital Management, LLC d/b/a Genter Capital Management ("Genter Capital" or the "Sub-Advisor") assessment of valuation and the economic outlook using the process described below. Examples of conditions that will affect the weighting of sectors include recent relative performance of each sector to the overall market performance, economic conditions such as inflation and economic growth and expectations of economic growth in the upcoming period of time and how that sector might be affected more or less than other sectors, and economic growth rate and geopolitical conditions, military conflicts which can typically affect availability and demand for natural resources that can have impact on one or more sectors relative to other sectors of the overall market economy. For example, the price of oil has a significant impact on the transportation sector, which can in turn have a significant impact on consumer goods and raw materials being transported. Another example which can have a significant impact on one or more sectors is tariffs. Tariffs imposed on either a country or a particular industry will increase the price and may reduce the supply as well. A tariff on consumer goods imported from China would impact retailers where those imported goods are sold. 2 The Sub-Advisor employs a three-step process in selecting the Fund's investments. The Sub-Advisor begins with a universe of domestic publicly traded companies that have paid a dividend in each of the previous four quarters. First, the Sub-Advisor uses publicly available filings, financial analyst's reports and research information available both publicly and by subscription or purchase to identify companies that have 1) tax-advantaged dividend payments which qualify for tax treatment as capital gains tax rates versus ordinary income tax rates, which will allow the Fund shareholder to recognize that portion of the Fund income dividend as receipt of capital gain, a lower tax rate than ordinary income dividends, 2) market capitalizations greater than $2 billion, 3) dividend per share increase of any amount versus prior quarter and 4) investment grade debt ratings. Second, a thorough fundamental analysis of the companies is conducted focusing on valuation and balance sheet and income statement information. Lastly, the four characteristics identified in the first step are evaluated further to assess the likelihood of capital appreciation, and to assess the expected volatility and risk for each security. The Sub-Advisor will sell a security when one or more of the following occurs: 1) the security's price target is realized; 2) an individual holding exceeds 5% of the portfolio; 3) dividend payment falls below acquisition parameters; 4) the company's underlying debt rating falls below investment grade; 5) sector rebalancing; 6) payout ratio (proportion of a company's earnings that is paid out to shareholders) exceeds proprietary forecasts of long-term sustainable earnings and free cash flow; 7) a fundamental development weakens a company's balance sheet or earnings potential (such as a rating agency downgrade of the debt held by a portfolio company to below investment grade); or 8) the Fund requires cash to meet redemption requests. 3 The Sub-Advisor will also sell call option contracts, that are based on the value of underlying securities held by the Fund, to generate income via option premiums.
Management and Contact
- Adviser
- OBP Capital LLC
- Sub-adviser
- Genter Capital Management
- Portfolio managers
-
David Pescherine, Senior Vice President of the Sub-Advisor, and David P. Klatt, Vice President of the Sub-Advisor are the Fund's portfolio managers and are jointly and primarily responsible for the day-to-day management of the Fund's portfolio.
Mr. Pescherine and Mr. Klatt have managed the Fund since its inception in January 2025.
- Phone
- 1-800-773-3863
- [email protected]
- Website
- genterfunds.com/GEND
Holdings as of Jul 31, 2026
The full portfolio as of the quarter end Jul 31, 2026, from the fund's report to the SEC (Form N-PORT, filed Sep 28, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of Apr 30, 2026.
33 lines, 32 linked, weights sum to 99.85% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| Northern Trust Corp | NTRS 665859104 | Equity | 1,245 | +66 | 4.67% | $ 226.827K |
| CVS Health Corp | US1266501006 | Equity | 2,080 | +112 | 4.47% | $ 217.214K |
| Enbridge Inc | CA29250N1050 | Equity | 3,671 | +198 | 4.12% | $ 199.923K |
| JPMorgan Chase & Co | US46625H1005 | Equity | 556 | +30 | 4.03% | $ 195.595K |
| M&T Bank Corp | MTB 55261F104 | Equity | 773 | −60 | 3.92% | $ 190.382K |
| Altria Group Inc | US02209S1033 | Equity | 2,746 | +148 | 3.86% | $ 187.634K |
| Devon Energy Corp | DVN 25179M103 | Equity | 4,109 | new +4,109 | 3.82% | $ 185.439K |
| Accenture PLC | IE00B4BNMY34 | Equity | 1,114 | +668 | 3.80% | $ 184.835K |
| Chevron Corp | CVX 166764100 | Equity | 933 | +50 | 3.78% | $ 183.642K |
|
Goldman Sachs Financ
|
FGTXX 38141W273 | Money market | 183,374.3 | +151,190.2 | 3.77% | $ 183.374K |
| Merck & Co Inc | US58933Y1055 | Equity | 1,347 | +72 | 3.61% | $ 175.379K |
| Phillips 66 | PSX 718546104 | Equity | 785 | +42 | 3.42% | $ 166.169K |
| Emerson Electric Co | US2910111044 | Equity | 1,044 | +56 | 3.22% | $ 156.412K |
| Comcast Corp | CMCSA 20030N101 | Equity | 6,451 | +2,283 | 3.18% | $ 154.566K |
| United Parcel Servic | US9113121068 | Equity | 1,445 | +78 | 3.10% | $ 150.598K |
| PepsiCo Inc | US7134481081 | Equity | 1,050 | +56 | 3.02% | $ 146.538K |
| Evergy Inc | EVRG 30034W106 | Equity | 1,747 | +94 | 2.99% | $ 145.018K |
| Medtronic PLC | MDT G5960L103 | Equity | 1,586 | +703 | 2.79% | $ 135.429K |
| BlackRock Inc | US09290D1019 | Equity | 122 | +6 | 2.74% | $ 133.028K |
| AT&T Inc | US00206R1023 | Equity | 5,727 | +609 | 2.74% | $ 133.153K |
| AbbVie Inc | US00287Y1091 | Equity | 526 | +28 | 2.72% | $ 131.994K |
| Capital One Financia | US14040H1059 | Equity | 631 | +34 | 2.71% | $ 131.885K |
| Johnson & Johnson | US4781601046 | Equity | 487 | −116 | 2.57% | $ 124.842K |
| Microchip Technology | MCHP 595017104 | Equity | 1,675 | +90 | 2.56% | $ 124.436K |
| Air Products & Chemi | APD 009158106 | Equity | 412 | +22 | 2.50% | $ 121.495K |
| Sempra Energy | US8168511090 | Equity | 1,371 | +74 | 2.50% | $ 121.402K |
| Gilead Sciences Inc | US3755581036 | Equity | 891 | −132 | 2.39% | $ 116.017K |
| Lockheed Martin Corp | US5398301094 | Equity | 193 | +10 | 2.32% | $ 112.469K |
| Bristol-Myers Squibb | US1101221083 | Equity | 1,704 | +92 | 2.29% | $ 111.288K |
| Cisco Systems Inc | US17275R1023 | Equity | 834 | −1,519 | 1.99% | $ 96.736K |
| CRH PLC | IE0001827041 | Equity | 859 | +46 | 1.68% | $ 81.614K |
| Home Depot Inc/The | US4370761029 | Equity | 228 | +12 | 1.56% | $ 75.687K |
| LKQ Corp | US5018892084 | Equity | 2,196 | +118 | 1.01% | $ 49.3K |
Trades Apr 30, 2026 to Jul 31, 2026
Changes in shares between the fund's two newest published portfolios, cash left out. Value is the change at the line's own price in the newer portfolio.
| Holding | Ticker | Action | Before | After | Change | Value |
|---|---|---|---|---|---|---|
|
Coterra Energy Inc
|
CTRA | Closed | 5,553 | — | −5,553 | $ -199.408K |
| Devon Energy Corp | DVN | New | — | 4,109 | +4,109 | $ 185.439K |
| Cisco Systems Inc | Sold | 2,353 | 834 | −1,519 | $ -176.189K | |
| Accenture PLC | Bought | 446 | 1,114 | +668 | $ 110.835K | |
| Corning Inc | GLW | Closed | 439 | — | −439 | $ -72.101K |
| Medtronic PLC | MDT | Bought | 883 | 1,586 | +703 | $ 60.029K |
| Comcast Corp | CMCSA | Bought | 4,168 | 6,451 | +2,283 | $ 54.701K |
| Johnson & Johnson | Sold | 603 | 487 | −116 | $ -29.737K | |
| Gilead Sciences Inc | Sold | 1,023 | 891 | −132 | $ -17.188K | |
| M&T Bank Corp | MTB | Sold | 833 | 773 | −60 | $ -14.777K |
| AT&T Inc | Bought | 5,118 | 5,727 | +609 | $ 14.159K | |
| Northern Trust Corp | NTRS | Bought | 1,179 | 1,245 | +66 | $ 12.025K |
| CVS Health Corp | Bought | 1,968 | 2,080 | +112 | $ 11.696K | |
| Enbridge Inc | Bought | 3,473 | 3,671 | +198 | $ 10.783K | |
| JPMorgan Chase & Co | Bought | 526 | 556 | +30 | $ 10.554K | |
| Altria Group Inc | Bought | 2,598 | 2,746 | +148 | $ 10.113K | |
| Chevron Corp | CVX | Bought | 883 | 933 | +50 | $ 9,841.50 |
| Merck & Co Inc | Bought | 1,275 | 1,347 | +72 | $ 9,374.40 | |
| Phillips 66 | PSX | Bought | 743 | 785 | +42 | $ 8,890.56 |
| Emerson Electric Co | Bought | 988 | 1,044 | +56 | $ 8,389.92 | |
| United Parcel Servic | Bought | 1,367 | 1,445 | +78 | $ 8,129.16 | |
| PepsiCo Inc | Bought | 994 | 1,050 | +56 | $ 7,815.36 | |
| Evergy Inc | EVRG | Bought | 1,653 | 1,747 | +94 | $ 7,802.94 |
| Capital One Financia | Bought | 597 | 631 | +34 | $ 7,106.34 | |
| AbbVie Inc | Bought | 498 | 526 | +28 | $ 7,026.32 | |
| Microchip Technology | MCHP | Bought | 1,585 | 1,675 | +90 | $ 6,686.10 |
| Sempra Energy | Bought | 1,297 | 1,371 | +74 | $ 6,552.70 | |
| BlackRock Inc | Bought | 116 | 122 | +6 | $ 6,542.34 | |
| Air Products & Chemi | APD | Bought | 390 | 412 | +22 | $ 6,487.58 |
| Bristol-Myers Squibb | Bought | 1,612 | 1,704 | +92 | $ 6,008.52 | |
| Lockheed Martin Corp | Bought | 183 | 193 | +10 | $ 5,827.40 | |
| CRH PLC | Bought | 813 | 859 | +46 | $ 4,370.46 | |
| Home Depot Inc/The | Bought | 216 | 228 | +12 | $ 3,983.52 | |
| LKQ Corp | Bought | 2,078 | 2,196 | +118 | $ 2,649.10 | |
|
Chevron Corp OPTION
|
Closed | -4 | — | +4 | $ 1,100.00 | |
|
Gilead Sciences Inc OPTION
|
Closed | -5 | — | +5 | $ 235.00 | |
|
Johnson & Johnson OPTION
|
Closed | -4 | — | +4 | $ 66.00 |
Podcast Mentions
Sign up to see podcast mentions and sentiment
Sign Up